Vestal Point Capital »

Solid Biosciences shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Solid Biosciences (SLDB) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Solid Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Solid Biosciences held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Solid Biosciences by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $15M 2.7M 5.67

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Solid Biosciences

Perceptive Advisors
RA Capital Management
Bain Capital Life Sciences Investors
Vestal Point Capital
Adage Capital Partners GP
Artal Group
Deerfield Management Company
Millennium Management
BlackRock
Vanguard Group
Finepoint Capital
Henderson Group
Walleye Trading Advisors
Geode Capital Management
Laurion Capital Management

View all funds holding Solid Biosciences